443 related articles for article (PubMed ID: 31189716)
1. Rational Design of Zika Virus Subunit Vaccine with Enhanced Efficacy.
Tai W; Chen J; Zhao G; Geng Q; He L; Chen Y; Zhou Y; Li F; Du L
J Virol; 2019 Sep; 93(17):. PubMed ID: 31189716
[TBL] [Abstract][Full Text] [Related]
2. Critical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika viruses.
Tai W; He L; Wang Y; Sun S; Zhao G; Luo C; Li P; Zhao H; Fremont DH; Li F; Jiang S; Zhou Y; Du L
Emerg Microbes Infect; 2018 Jan; 7(1):7. PubMed ID: 29362446
[TBL] [Abstract][Full Text] [Related]
3. Role of Zika Virus Envelope Protein Domain III as a Target of Human Neutralizing Antibodies.
Gallichotte EN; Young EF; Baric TJ; Yount BL; Metz SW; Begley MC; de Silva AM; Baric RS
mBio; 2019 Sep; 10(5):. PubMed ID: 31530669
[TBL] [Abstract][Full Text] [Related]
4. Insect cell-produced recombinant protein subunit vaccines protect against Zika virus infection.
Qu P; Zhang W; Li D; Zhang C; Liu Q; Zhang X; Wang X; Dai W; Xu Y; Leng Q; Zhong J; Jin X; Huang Z
Antiviral Res; 2018 Jun; 154():97-103. PubMed ID: 29665376
[TBL] [Abstract][Full Text] [Related]
5. Yeast-produced subunit protein vaccine elicits broadly neutralizing antibodies that protect mice against Zika virus lethal infection.
Zhang W; Qu P; Li D; Zhang C; Liu Q; Zou G; Dupont-Rouzeyrol M; Lavillette D; Jin X; Yin F; Huang Z
Antiviral Res; 2019 Oct; 170():104578. PubMed ID: 31394119
[TBL] [Abstract][Full Text] [Related]
6. Zika Virus-Like Particles Bearing a Covalent Dimer of Envelope Protein Protect Mice from Lethal Challenge.
De Lorenzo G; Tandavanitj R; Doig J; Setthapramote C; Poggianella M; Sanchez-Velazquez R; Scales HE; Edgar JM; Kohl A; Brewer J; Burrone OR; Patel AH
J Virol; 2020 Dec; 95(1):. PubMed ID: 33028720
[TBL] [Abstract][Full Text] [Related]
7. Dengue virus envelope protein domain III-elicited antibodies mediate cross-protection against Zika virus in a mouse model.
Zhou Y; Chen D; Yang L; Zou W; Duan Z; Zhang Y; Wen J
Virus Res; 2020 Mar; 278():197882. PubMed ID: 31981774
[TBL] [Abstract][Full Text] [Related]
8. Development of Envelope Protein Antigens To Serologically Differentiate Zika Virus Infection from Dengue Virus Infection.
Premkumar L; Collins M; Graham S; Liou GA; Lopez CA; Jadi R; Balmaseda A; Brackbill JA; Dietze R; Camacho E; De Silva AD; Giuberti C; Dos Reis HL; Singh T; Heimsath H; Weiskopf D; Sette A; Osorio JE; Permar SR; Miley MJ; Lazear HM; Harris E; de Silva AM
J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29263206
[TBL] [Abstract][Full Text] [Related]
9. Immunization of Zika virus envelope protein domain III induces specific and neutralizing immune responses against Zika virus.
Yang M; Dent M; Lai H; Sun H; Chen Q
Vaccine; 2017 Jul; 35(33):4287-4294. PubMed ID: 28669618
[TBL] [Abstract][Full Text] [Related]
10. Dengue and Zika Virus Domain III-Flagellin Fusion and Glycan-Masking E Antigen for Prime-Boost Immunization.
Lin HH; Yang SP; Tsai MJ; Lin GC; Wu HC; Wu SC
Theranostics; 2019; 9(16):4811-4826. PubMed ID: 31367259
[TBL] [Abstract][Full Text] [Related]
11. Vaccine protection against Zika virus from Brazil.
Larocca RA; Abbink P; Peron JP; Zanotto PM; Iampietro MJ; Badamchi-Zadeh A; Boyd M; Ng'ang'a D; Kirilova M; Nityanandam R; Mercado NB; Li Z; Moseley ET; Bricault CA; Borducchi EN; Giglio PB; Jetton D; Neubauer G; Nkolola JP; Maxfield LF; De La Barrera RA; Jarman RG; Eckels KH; Michael NL; Thomas SJ; Barouch DH
Nature; 2016 Aug; 536(7617):474-8. PubMed ID: 27355570
[TBL] [Abstract][Full Text] [Related]
12. Japanese encephalitis virus E protein domain III immunization mediates cross-protection against Zika virus in mice via antibodies and CD8
Duan ZL; Zou WW; Chen D; Zhu JY; Wen JS
Virus Res; 2024 Jul; 345():199376. PubMed ID: 38643856
[TBL] [Abstract][Full Text] [Related]
13. Re-burying Artificially Exposed Surface of Viral Subunit Vaccines Through Oligomerization Enhances Vaccine Efficacy.
Han X; Cai Z; Dai Y; Huang H; Cao X; Wang Y; Fang Y; Liu G; Zhang M; Zhang Y; Yang B; Xue W; Zhao G; Tai W; Li M
Front Cell Infect Microbiol; 2022; 12():927674. PubMed ID: 35846760
[TBL] [Abstract][Full Text] [Related]
14. Two immunogenic recombinant protein vaccine candidates showed disparate protective efficacy against Zika virus infection in rhesus macaques.
Yang R; Liu Q; Pang W; Gao F; Liang H; Zhang W; Lin Y; Li M; Liu Z; Gao GF; Zhang L; Xiao H; Zheng Y; Huang Z; Jin X
Vaccine; 2021 Feb; 39(6):915-925. PubMed ID: 33451779
[TBL] [Abstract][Full Text] [Related]
15. Convalescent patient-derived monoclonal antibodies targeting different epitopes of E protein confer protection against Zika virus in a neonatal mouse model.
Niu X; Zhao L; Qu L; Yao Z; Zhang F; Yan Q; Zhang S; Liang R; Chen P; Luo J; Xu W; Lv H; Liu X; Lei H; Yi C; Li P; Wang Q; Wang Y; Yu L; Zhang X; Bryan LA; Davidson E; Doranz JB; Feng L; Pan W; Zhang F; Chen L
Emerg Microbes Infect; 2019; 8(1):749-759. PubMed ID: 31130109
[TBL] [Abstract][Full Text] [Related]
16. Probing Zika Virus Neutralization Determinants with Glycoprotein Mutants Bearing Linear Epitope Insertions.
Chambers MT; Schwarz MC; Sourisseau M; Gray ES; Evans MJ
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976678
[TBL] [Abstract][Full Text] [Related]
17. Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis Damage.
Xu K; Song Y; Dai L; Zhang Y; Lu X; Xie Y; Zhang H; Cheng T; Wang Q; Huang Q; Bi Y; Liu WJ; Liu W; Li X; Qin C; Shi Y; Yan J; Zhou D; Gao GF
J Virol; 2018 Mar; 92(6):. PubMed ID: 29298885
[TBL] [Abstract][Full Text] [Related]
18. A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection.
Slon-Campos JL; Dejnirattisai W; Jagger BW; López-Camacho C; Wongwiwat W; Durnell LA; Winkler ES; Chen RE; Reyes-Sandoval A; Rey FA; Diamond MS; Mongkolsapaya J; Screaton GR
Nat Immunol; 2019 Oct; 20(10):1291-1298. PubMed ID: 31477918
[TBL] [Abstract][Full Text] [Related]
19. Rational Engineering and Characterization of an mAb that Neutralizes Zika Virus by Targeting a Mutationally Constrained Quaternary Epitope.
Tharakaraman K; Watanabe S; Chan KR; Huan J; Subramanian V; Chionh YH; Raguram A; Quinlan D; McBee M; Ong EZ; Gan ES; Tan HC; Tyagi A; Bhushan S; Lescar J; Vasudevan SG; Ooi EE; Sasisekharan R
Cell Host Microbe; 2018 May; 23(5):618-627.e6. PubMed ID: 29746833
[TBL] [Abstract][Full Text] [Related]
20. Preventative Vaccines for Zika Virus Outbreak: Preliminary Evaluation.
Kim E; Erdos G; Huang S; Kenniston T; Falo LD; Gambotto A
EBioMedicine; 2016 Nov; 13():315-320. PubMed ID: 27717627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
